Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioScan Research is a medical technology company that develops non-invasive, portable screening tools for the early detection of life-threatening conditions. Its flagship product, Mobile Vision (formerly known as Neuro-Touch), is a handheld device that utilizes near-infrared spectroscopy (NIRS) to detect intracranial hemorrhage (ICH) in trauma patients at the point of care. The company's technology is designed to provide rapid, accurate diagnostics in emergency settings, enabling healthcare providers to prioritize patients for CT scans and surgical intervention. BioScan Research is primarily focused on improving outcomes in neurology and emergency medicine through accessible and cost-effective diagnostic solutions, particularly in resource-limited environments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioScan Technologies.